One of the highest yields you can get right now is from Pfizer (NYSE: PFE). The healthcare giant offers a yield of 6.8%, ...

Three Motley Fool contributors think they've found unstoppable dividend stocks to buy right now. Here's why they picked ...

Pfizer's diversified pipeline and new product launches are driving operational growth. Click here to read more about PFE ...

Pfizer Inc. (NYSE:PFE) discovers, develops, markets, and sells biopharmaceutical products in the U.S. and internationally. It ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

Realty Income is a real estate investment trust that has raised its dividend payout 131 times since 1994. Verizon's a ...

A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...

Pfizer is a solid dividend stock. Its forward yield currently tops 7%, and the company has increased its payouts by 19.5% in ...

These three dividend stocks are trading on the cheap given their true valuations. They should be on income investors' radars.

Pfizer Q2: Dividends Speak Louder Than EPS Aug. 06, 2025 5:42 PM ET Pfizer Inc. (PFE) Stock, PFE:CA Stock PFE, PFE:CA 45 Comments 2 Likes Envision Research Investing Group Leader Follow ...

Here is why Pfizer's newfound momentum could set the stock up to soar in 2026. Image source: Getty Images. Pfizer's generous dividend has become a big reason why many people consider owning the stock.

Looking ahead, Pfizer Inc. (NYSE:PFE) plans to achieve $7.2 billion in cost savings by 2027, which should improve cash flow and provide more flexibility for sustaining its dividend.